San Bruno, CA, United States of America

Lee Ann Lynn Schillinger


 

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Lee Ann Lynn Schillinger

Introduction

Lee Ann Lynn Schillinger, an accomplished inventor based in San Bruno, California, has made significant strides in the field of drug delivery systems. With four patents to her name, she continues to push the boundaries of innovation, particularly in the area of biodegradable polymers.

Latest Patents

Among her notable contributions is her work on "Compositions of a polyorthoester and an aprotic solvent." This patent describes delivery systems and compositions that utilize a biodegradable polyorthoester polymer combined with an aprotic solvent and a drug. The unique feature of her invention lies in the solvent's ability to modulate drug release from the composition. In certain embodiments, the solvent is rapidly released post-administration, leading to a quick release of the drug. In contrast, other embodiments allow for a gradual release of the solvent, providing a slower rate of drug release, thereby optimizing therapeutic effectiveness.

Career Highlights

Lee Ann Lynn Schillinger is currently employed at Heron Therapeutics, Inc., where she harnesses her expertise to develop innovative therapeutic solutions. Her dedication to advancing health care technology is evident in her numerous patents, which reflect her commitment to improving drug delivery systems.

Collaborations

In her professional journey, Lee Ann has collaborated with esteemed colleagues, including Thomas B. Ottoboni and Joseph Niemann. These collaborations have undoubtedly enriched her work, allowing her to explore innovative solutions and drive forward-thinking research in the biopharmaceutical sector.

Conclusion

Lee Ann Lynn Schillinger's contributions to the field of drug delivery are significant, showcasing her innovative spirit and commitment to advancing medical technology. Her work in drug release modulation promises to enhance therapeutic outcomes, marking her as a notable inventor at the forefront of biopharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…